Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Warm Autoimmune Hemolytic Anemia (WAIHA)”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Testing effectiveness (Phase 2)Looking for participantsNCT07039422
What this trial is testing

Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

Who this might be right for
Primary Immune ThrombocytopeniaWarm Autoimmune Hemolytic Anemia
Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05757570
What this trial is testing

An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias

Who this might be right for
Immune ThrombocytopeniaIdiopathic Thrombocytopenic PurpuraWarm Autoimmune Hemolytic Anemia+1 more
Alpine Immune Sciences, Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT03075878
What this trial is testing

A Safety Study of SYNT001 in Participants With Warm Autoimmune Hemolytic Anemia (WAIHA)

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Alexion Pharmaceuticals, Inc. 8
Large-scale testing (Phase 3)Study completedNCT03764618
What this trial is testing

A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA

Who this might be right for
Warm Antibody Autoimmune Hemolytic Anemia
Rigel Pharmaceuticals 90
Testing effectiveness (Phase 2)Study completedNCT03226678
What this trial is testing

Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With Warm Type Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD)

Who this might be right for
Warm Autoimmune Hemolytic AnemiaCold Agglutinin Disease
Apellis Pharmaceuticals, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT04691570
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)

Who this might be right for
Warm Autoimmune Hemolytic Anemia (wAIHA)
Annexon, Inc. 6
Testing effectiveness (Phase 2)Ended earlyNCT04253236
What this trial is testing

To Assess the Efficacy and Safety of RVT-1401 in the Treatment of Warm Autoimmune Hemolytic Anemia (ASCEND-WAIHA).

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Immunovant Sciences GmbH 5
Testing effectiveness (Phase 2)Looking for participantsNCT05922839
What this trial is testing

Zanubrutinib in the Treatment of Relapsed/Refractory wAIHA

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Chen Miao 22
Early research (Phase 1)Study completedNCT02502903
What this trial is testing

Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders

Who this might be right for
Bullous Pemphigoid (BP)Cold Agglutinin Disease (CAD)Warm Autoimmune Hemolytic Anemia (WAIHA)+1 more
Bioverativ, a Sanofi company 122
Large-scale testing (Phase 3)Looking for participantsNCT07086976
What this trial is testing

Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Haemolytic Anaemia
Sanofi 90
Testing effectiveness (Phase 2)WithdrawnNCT04256148
What this trial is testing

ALXN1830 in Patients With Warm Autoimmune Hemolytic Anemia

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Alexion Pharmaceuticals, Inc.
Not applicableTemporarily Not AvailableNCT05221619
What this trial is testing

Post-trial Access for Nipocalimab in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Janssen Research & Development, LLC
Large-scale testing (Phase 3)Enrolling By InvitationNCT04138927
What this trial is testing

Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

Who this might be right for
Warm Antibody Autoimmune Hemolytic Anemia
Rigel Pharmaceuticals 90
Large-scale testing (Phase 3)Active Not RecruitingNCT05786573
What this trial is testing

Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Zenas BioPharma (USA), LLC 134
Large-scale testing (Phase 3)Looking for participantsNCT04119050
What this trial is testing

Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Janssen Research & Development, LLC 111
Testing effectiveness (Phase 2)WithdrawnNCT04956276
What this trial is testing

Subcutaneous ALXN1830 in Adult Participants With Warm Autoimmune Hemolytic Anemia

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Alexion Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT04661033
What this trial is testing

Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia (wAIHA)

Who this might be right for
Warm Autoimmune Hemolytic Anemia (wAIHA)
Sanofi 8
Large-scale testing (Phase 3)Ended earlyNCT05073458
What this trial is testing

Study of the Efficacy and Safety of Parsaclisib in Participants With Primary Warm Autoimmune Hemolytic Anemia

Who this might be right for
Warm Autoimmune Hemolytic Anemia (wAIHA)
Incyte Corporation 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT05002777
What this trial is testing

Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA)

Who this might be right for
Warm Autoimmune Hemolytic Anemia (wAIHA)
Sanofi 22
Large-scale testing (Phase 3)Active Not RecruitingNCT05648968
What this trial is testing

Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia

Who this might be right for
Warm Autoimmune Hemolytic Anemia (wAIHA)
Novartis Pharmaceuticals 90
Load More Results